Venmax Drugs and Pharmaceuticals Limited (BOM:531015)

BOM:531015 Statistics

Total Valuation

BOM:531015 has a market cap or net worth of INR 201.40 million. The enterprise value is 176.24 million.

Market Cap	201.40M
Enterprise Value	176.24M

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	n/a

Share Statistics

BOM:531015 has 8.01 million shares outstanding. The number of shares has decreased by -1.76% in one year.

Current Share Class	8.01M
Shares Outstanding	8.01M
Shares Change (YoY)	-1.76%
Shares Change (QoQ)	-7.36%
Owned by Insiders (%)	38.78%
Owned by Institutions (%)	1.25%
Float	4.80M

Valuation Ratios

The trailing PE ratio is 37.86.

PE Ratio	37.86
Forward PE	n/a
PS Ratio	6.58
PB Ratio	2.35
P/TBV Ratio	2.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	51.10
EV / Sales	5.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.68, with a Debt / Equity ratio of 0.36.

Current Ratio	2.68
Quick Ratio	1.84
Debt / Equity	0.36
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 9.04% and return on invested capital (ROIC) is -15.32%.

Return on Equity (ROE)	9.04%
Return on Assets (ROA)	-5.70%
Return on Invested Capital (ROIC)	-15.32%
Return on Capital Employed (ROCE)	-7.48%
Weighted Average Cost of Capital (WACC)	-56.66%
Revenue Per Employee	15.30M
Profits Per Employee	1.72M
Employee Count	2
Asset Turnover	0.44
Inventory Turnover	n/a

Taxes

In the past 12 months, BOM:531015 has paid 171,000 in taxes.

Income Tax	171,000
Effective Tax Rate	4.72%

Stock Price Statistics

The stock price has increased by +0.59% in the last 52 weeks. The beta is -12.66, so BOM:531015's price volatility has been lower than the market average.

Beta (5Y)	-12.66
52-Week Price Change	+0.59%
50-Day Moving Average	27.46
200-Day Moving Average	26.82
Relative Strength Index (RSI)	42.91
Average Volume (20 Days)	1,547

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:531015 had revenue of INR 30.61 million and earned 3.45 million in profits. Earnings per share was 0.66.

Revenue	30.61M
Gross Profit	3.33M
Operating Income	-6.42M
Pretax Income	3.62M
Net Income	3.45M
EBITDA	-6.36M
EBIT	-6.42M
Earnings Per Share (EPS)	0.66

Balance Sheet

The company has 56.23 million in cash and 31.07 million in debt, with a net cash position of 25.16 million or 3.14 per share.

Cash & Cash Equivalents	56.23M
Total Debt	31.07M
Net Cash	25.16M
Net Cash Per Share	3.14
Equity (Book Value)	85.77M
Book Value Per Share	17.58
Working Capital	85.40M

Cash Flow

Operating Cash Flow	-63.16M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 10.89%, with operating and profit margins of -20.96% and 11.27%.

Gross Margin	10.89%
Operating Margin	-20.96%
Pretax Margin	11.83%
Profit Margin	11.27%
EBITDA Margin	-20.79%
EBIT Margin	-20.96%
FCF Margin	n/a

Dividends & Yields

BOM:531015 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.76%
Shareholder Yield	1.76%
Earnings Yield	1.71%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 29, 2009. It was a reverse split with a ratio of 0.5.

Last Split Date	Jan 29, 2009
Split Type	Reverse
Split Ratio	0.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	3